dr. radich on the utility of mrd in hematologic malignancies
Published 4 years ago • 72 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:00
dr. radich on the evolving role of mrd in hematologic malignancies
-
1:01
dr. radich on measuring mrd in hematologic malignancies
-
1:05
dr. radich on impact of mrd in acute vs chronic leukemias
-
5:27
mrd testing in hematologic malignancies other than all
-
0:57
dr. daver discusses use of mrd assessment in hematologic malignancies
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
11:24
what causes clotting from med ref ch 39
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
3:31
mrd testing in hematologic malignancies
-
7:39
understanding mrd
-
10:49
amp 2016 mrd solutions for the studies of hematologic malignancies – flt3 itd mrd
-
22:56
measurable residual disease (mrd) in aml and all
-
4:35
learn about measurable residual disease (mrd)
-
2:03
updated fda mrd guidelines for hematological malignancies
-
5:51
establishing mrd’s role in all management
-
1:46
importance of mrd monitoring in all
-
1:27
the real world utilization of mrd in myeloma across europe
-
27:03
mrd/cr1 and the role of allogeneic transplant: what is first remission?
-
1:27
maintenance therapy and mrd in myeloma
-
19:41
multiple myeloma: minimal residual disease
-
21:09
minimal residual disease (mrd) in cll: is it clinically relevant?
-
0:48
myeloma prognosis - the emergence of mrd